✦ LIBER ✦

Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost

✍ Scribed by Judit Végh; Györgyike Soós; István Csipõ; Nóra Demeter; Thomas Ben; Balázs Dezsõ; Margit Zeher; Katalin Dévényi; János Gaál; Gyula Szegedi; Edit Bodolay

Publisher: Springer
Year: 2005
Tongue: English
Weight: 441 KB
Volume: 26
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-005-0616-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vanishing Pulmonary Hypertension in Mixe

Vanishing Pulmonary Hypertension in Mixed Connective Tissue Disease

✍ I. E. E. Lahaye; P. E. M. Rogiers; J. M. Nagler; R. Chappel 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 26 KB

Efficacy of bosentan in the treatment of

Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension

✍ Caterina Naclerio; Salvatore D’Angelo; Silvano Baldi; Gianluigi Tagliamonte; Sal 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 99 KB

Pulmonary arterial hypertension among Fi

Pulmonary arterial hypertension among Filipino patients with connective tissue diseases

✍ Paul V. Santos Estrella; Yih Chang Lin; Sandra V. Navarra 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 185 KB

Pulmonary capillary endothelial metaboli

Pulmonary capillary endothelial metabolic dysfunction: Severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension

✍ David Langleben; Stylianos E. Orfanos; Michele Giovinazzo; Andrew Hirsch; Murray 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

Classification tree criteria of pulmonar

Classification tree criteria of pulmonary hypertension in mixed connective tissue disease

✍ Kotajima, Lisa ;Aotsuka, Shinichi ;Nishimaki, Tomoe ;Kashiwagi, Heihachiro ;Kuni 📂 Article 📅 1997 🏛 Informa UK (Informa Healthcare) 🌐 English ⚖ 568 KB

Long-term iloprost infusion therapy for

Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases

✍ Jose De La Mata; Miguel A. Gomez-Sanchez; Mercedes Aranzana; Juan J. Gomez-Reino 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had